- Home
- HPS vs NPCE Comparison
HPS vs NPCE Comparison
Compare HPS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPS
- NPCE
- Stock Information
- Founded
- HPS 2003
- NPCE 1997
- Country
- HPS United States
- NPCE United States
- Employees
- HPS N/A
- NPCE N/A
- Industry
- HPS Investment Managers
- NPCE Medical Specialities
- Sector
- HPS Finance
- NPCE Health Care
- Exchange
- HPS Nasdaq
- NPCE Nasdaq
- Market Cap
- HPS 445.5M
- NPCE 358.3M
- IPO Year
- HPS N/A
- NPCE 2021
- Fundamental
- Price
- HPS $14.22
- NPCE $12.58
- Analyst Decision
- HPS
- NPCE Buy
- Analyst Count
- HPS 0
- NPCE 7
- Target Price
- HPS N/A
- NPCE $15.14
- AVG Volume (30 Days)
- HPS 58.4K
- NPCE 482.1K
- Earning Date
- HPS 01-01-0001
- NPCE 05-13-2025
- Dividend Yield
- HPS 8.62%
- NPCE N/A
- EPS Growth
- HPS N/A
- NPCE N/A
- EPS
- HPS N/A
- NPCE N/A
- Revenue
- HPS N/A
- NPCE $84,306,000.00
- Revenue This Year
- HPS N/A
- NPCE $20.74
- Revenue Next Year
- HPS N/A
- NPCE $12.47
- P/E Ratio
- HPS N/A
- NPCE N/A
- Revenue Growth
- HPS N/A
- NPCE 22.05
- 52 Week Low
- HPS $11.79
- NPCE $5.45
- 52 Week High
- HPS $15.40
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- HPS 43.70
- NPCE 43.01
- Support Level
- HPS $14.15
- NPCE $10.61
- Resistance Level
- HPS $14.32
- NPCE $13.25
- Average True Range (ATR)
- HPS 0.14
- NPCE 1.64
- MACD
- HPS -0.01
- NPCE -0.52
- Stochastic Oscillator
- HPS 20.21
- NPCE 23.49
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.